ZBED6 is a zinc finger transcription factor and domesticated DNA transposon-derived protein that functions as a context-dependent regulator of cell growth and metabolism 1. As a transcriptional repressor, ZBED6 binds the consensus sequence 5'-GCTCGC-3' and regulates multiple target genes including IGF2, CDH2, and PRC 12. In skeletal muscle, ZBED6 suppresses IGF2 expression, thereby negatively regulating postnatal growth and myoblast differentiation 1. Conversely, in pancreatic beta cells, ZBED6 promotes proliferation and survival while suppressing specialized insulin production, with nuclear ZBED6 forms enriched in rapidly proliferating cells 3. ZBED6 regulates beta cell adhesion by repressing N-cadherin (CDH2) transcription, affecting cell-to-cell junctions 4. Clinically, ZBED6 dysfunction associates with disease: loss of ZBED6 protects against sepsis-induced muscle atrophy through DOCK3 upregulation and RAC1/PI3K/AKT pathway activation 5, while reduced ZBED6 expression in glioblastoma promotes migration via dysregulated Wnt/β-catenin signaling and poor patient prognosis 6. ZBED6 expression effects on colorectal cancer growth are context-dependent, reflecting its tissue and genetic background-specific functions 7.